The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors-Reference-Cited by-同舟云学术

The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors

Published:1998-05 Issue:7 Volume:12 Page:705-712
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Miller Veronica,Stürmer Martin,Staszewski Schlomo,Gröschel Bettina,Hertogs Kurt,de Béthune Marie-Pierre,Pauwels Rudi,Harrigan P Richard,Bloor Stuart,Kemp Sharon D.,Larder Brendan A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference17 articles.

1. Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments

2. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

3. Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients

4. Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy

5. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China;AIDS Research and Human Retroviruses;2022-06-01

2. Measurement and comprehensive analysis of the solubility of abacavir in twelve pure solvents;Journal of Molecular Liquids;2021-09

3. Characterizing HIV-1 Genetic Subtypes and Drug Resistance Mutations among Children, Adolescents and Pregnant Women in Sierra Leone;Genes;2021-08-26

4. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease;mBio;2018-05-02

5. The risk of HIV drug resistance following implementation of pre-exposure prophylaxis;Current Opinion in Infectious Diseases;2010-12